The company intends to sell 5 million shares of common stock, with underwriters holding a 30-day option for an additional 750,000 units to cover over-allotments. Nuvectis expects to generate $100 million in gross proceeds from the transaction. Management plans to funnel these funds into pipeline development, personnel expansion, and general capital expenditures.

Nuvectis first signaled its intent to initiate the offering after Monday's market close, though it withheld specific pricing and volume details until Tuesday. The market's reaction reflects a cautious recalibration following the company's recent surge, as shareholders weigh the impact of potential dilution against the firm's long-term development goals.